OverT Bio

Finding new genes to power transformative cell therapies.

[OverT Bio @OverT_Bio]

Excited to share a big milestone for OverT Bio—we’ve formed our Clinical Advisory Board.

Grateful to partner with an incredible group of leaders as we build scalable γδ CAR-T therapies for solid tumors.

https://t.co/NqeIFVIilG

[LifeSci Startup @LSciStartupNews]

One more biotech coming out of stealth! OverT Bio debuts with $16M to find new ways to make solid cancer cell therapies. Read it here: https://t.co/avLCI5gCgX
@OverT_Bio

[Neville Sanjana @nevillesanjana]

Congrats to @MatLegut & the entire @OverT_Bio team! Grateful for the opportunity to translate discoveries from our lab @nygenome & @nyuniversity into therapies for cancer patients.

Thrilled to be a part of this amazing team — onward and upward! 🚀

[OverT Bio @OverT_Bio]

Grateful to @artisventures, @wing_vc, and all our investors. Shout-out to early believers @vasudevbailey and @sarachoi_ and the founding team @nevillesanjana and @matlegut

[OverT Bio @OverT_Bio]

We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers.

https://t.co/mKj8OiXrk0

[OverT Bio @OverT_Bio]

How? We screen tens of thousands of genetic enhancements and receptors to build the optimal therapeutic cells. Our decisions are guided by data, not assumptions. https://t.co/kREEzSXmYI